Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin

EU orphan designation number: EU/3/15/1470   
Active ingredient: 5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin
Indication: Treatment of biliary tract cancer
Sponsor: Luzitin S.A
Edificio Bluepharma, Sao Martinho do Bispo, Coimbra 3045-016, Portugal

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/03/2015 Orphan designation EMA/OD/305/14 (2015)2039 of 19/03/2015